BR9708449A - Composto processos para o tratamento ou profilaxia da bronquite cronica e de uma doenca pulmonar obstrutiva cronica e para preparação de uma doenca pulmonar obstrutiva cronica e para preparação de um composto e utilização de um composto - Google Patents

Composto processos para o tratamento ou profilaxia da bronquite cronica e de uma doenca pulmonar obstrutiva cronica e para preparação de uma doenca pulmonar obstrutiva cronica e para preparação de um composto e utilização de um composto

Info

Publication number
BR9708449A
BR9708449A BR9708449A BR9708449A BR9708449A BR 9708449 A BR9708449 A BR 9708449A BR 9708449 A BR9708449 A BR 9708449A BR 9708449 A BR9708449 A BR 9708449A BR 9708449 A BR9708449 A BR 9708449A
Authority
BR
Brazil
Prior art keywords
preparing
compound
pulmonary disease
obstructive pulmonary
chronic obstructive
Prior art date
Application number
BR9708449A
Other languages
English (en)
Inventor
Michael Dennis Dowle
Harry Finch
Andrew Lee
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606508.1A external-priority patent/GB9606508D0/en
Priority claimed from GBGB9623001.6A external-priority patent/GB9623001D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BR9708449A publication Critical patent/BR9708449A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
BR9708449A 1996-03-28 1997-03-26 Composto processos para o tratamento ou profilaxia da bronquite cronica e de uma doenca pulmonar obstrutiva cronica e para preparação de uma doenca pulmonar obstrutiva cronica e para preparação de um composto e utilização de um composto BR9708449A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606508.1A GB9606508D0 (en) 1996-03-28 1996-03-28 Chemical componds
GBGB9623001.6A GB9623001D0 (en) 1996-11-05 1996-11-05 Chemical compounds
PCT/EP1997/001530 WO1997036903A1 (en) 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (1)

Publication Number Publication Date
BR9708449A true BR9708449A (pt) 1999-08-03

Family

ID=26309008

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708449A BR9708449A (pt) 1996-03-28 1997-03-26 Composto processos para o tratamento ou profilaxia da bronquite cronica e de uma doenca pulmonar obstrutiva cronica e para preparação de uma doenca pulmonar obstrutiva cronica e para preparação de um composto e utilização de um composto

Country Status (30)

Country Link
US (3) US5994344A (pt)
EP (1) EP0891362B1 (pt)
JP (1) JP4118337B2 (pt)
KR (1) KR20000005039A (pt)
CN (1) CN1067075C (pt)
AP (1) AP823A (pt)
AR (1) AR006401A1 (pt)
AT (1) ATE261969T1 (pt)
AU (1) AU726649B2 (pt)
BR (1) BR9708449A (pt)
CA (1) CA2250209A1 (pt)
CO (1) CO4790152A1 (pt)
CZ (1) CZ309798A3 (pt)
DE (1) DE69728139T2 (pt)
DK (1) DK0891362T3 (pt)
EA (1) EA001437B1 (pt)
EE (1) EE9800335A (pt)
ES (1) ES2217404T3 (pt)
HU (1) HUP9900567A3 (pt)
IL (1) IL125859A0 (pt)
IS (1) IS4837A (pt)
NO (1) NO984470L (pt)
NZ (1) NZ331490A (pt)
PE (1) PE55298A1 (pt)
PL (1) PL329153A1 (pt)
PT (1) PT891362E (pt)
SK (1) SK132498A3 (pt)
TR (1) TR199801935T2 (pt)
WO (1) WO1997036903A1 (pt)
YU (1) YU41198A (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719189D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
GB9719172D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719187D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
BRPI0408332A (pt) 2003-03-14 2006-03-21 Ono Pharmaceutical Co derivados heterocìclicos contendo nitrogênio e medicamentos contendo os mesmos como ingrediente ativo
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7692037B2 (en) * 2004-09-02 2010-04-06 Eastman Chemical Company Optimized liquid-phase oxidation
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
CN101775013A (zh) * 2004-09-13 2010-07-14 小野药品工业株式会社 含氮杂环衍生物及含有其作为活性成分的药物
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
WO2007105637A1 (ja) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
CA2866037C (en) * 2007-04-23 2017-05-16 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
CN101910131B (zh) 2007-11-16 2014-04-23 里格尔药品股份有限公司 甲酰胺、磺酰胺和胺化合物及其使用方法
WO2009076631A1 (en) 2007-12-12 2009-06-18 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
DK2935274T3 (en) * 2012-12-18 2018-11-26 Chiesi Farm Spa 3-OXO-2,3,5,8-TETRAHYDRO- [1,2,4] TRIAZOLO [4,3-A] PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF AIR TRACT
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
IL297211A (en) 2020-04-16 2022-12-01 Mereo Biopharma 4 Ltd Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932650A (en) * 1957-11-19 1960-04-12 Arthur C Cope 2-6-diazabicyclo (3. 3. 0) octanes
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Also Published As

Publication number Publication date
EA199800773A1 (ru) 1999-06-24
JP2000507950A (ja) 2000-06-27
YU41198A (sh) 1999-09-27
IS4837A (is) 1998-08-28
CZ309798A3 (cs) 1999-02-17
DE69728139T2 (de) 2004-10-21
HUP9900567A3 (en) 2001-02-28
NZ331490A (en) 2000-06-23
AU726649B2 (en) 2000-11-16
SK132498A3 (en) 1999-08-06
US6057457A (en) 2000-05-02
US5994344A (en) 1999-11-30
IL125859A0 (en) 1999-04-11
NO984470D0 (no) 1998-09-25
AP9801351A0 (en) 1998-09-30
JP4118337B2 (ja) 2008-07-16
PL329153A1 (en) 1999-03-15
DK0891362T3 (da) 2004-07-12
CO4790152A1 (es) 1999-05-31
EP0891362A1 (en) 1999-01-20
KR20000005039A (ko) 2000-01-25
DE69728139D1 (de) 2004-04-22
TR199801935T2 (xx) 1999-03-22
PE55298A1 (es) 1998-09-19
EE9800335A (et) 1999-04-15
AU2291797A (en) 1997-10-22
HUP9900567A2 (hu) 1999-06-28
PT891362E (pt) 2004-08-31
US6215002B1 (en) 2001-04-10
EA001437B1 (ru) 2001-02-26
CN1067075C (zh) 2001-06-13
CN1219935A (zh) 1999-06-16
ATE261969T1 (de) 2004-04-15
AP823A (en) 2000-04-25
AR006401A1 (es) 1999-08-25
ES2217404T3 (es) 2004-11-01
EP0891362B1 (en) 2004-03-17
NO984470L (no) 1998-11-25
WO1997036903A1 (en) 1997-10-09
CA2250209A1 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
BR9708449A (pt) Composto processos para o tratamento ou profilaxia da bronquite cronica e de uma doenca pulmonar obstrutiva cronica e para preparação de uma doenca pulmonar obstrutiva cronica e para preparação de um composto e utilização de um composto
MX9201235A (es) Procedimiento para la fabricacion de boehmita dispersable.
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
NO20003038L (no) 4(3)Substituerte-4(3)-aminometyl-(tio)pyran eller - piperidinderivater (=gabapentinanaloger), deres fremstilling og deres anvendelse ved behandling av neurologiske lidelser
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
BR9709915A (pt) Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto
AU1842395A (en) Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
BR9507166A (pt) Conjunto de dentes para tratamento de uma superfície
AU3375693A (en) Method of the treatment of dry nose syndrome
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
BR9502471A (pt) Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica
IT8922168A0 (it) Procedura per il trattamento di legno d'abete e di legno duro
BR9709196A (pt) Derivados de azetidinona para o tratamento de aterosclerose
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
PT777457E (pt) A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses
FI961380A (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
PT853959E (pt) Composicao para o tratamento do amianto
ITMI941584A0 (it) Procedimento per la protezione delle superfici lapidee o di rivestimento
ITRM930226A0 (it) Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione.
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]